In mice, the targeting of tumor antigens to cDC1, using XCL1 or mAbs as vectors, proved to elicit a potent CTL response, preventing the outgrowth of inoculated tumors without relevant adverse effects [110,111,112]. Here, MPPE1 is linked to neoplasm.